검색

상세정보

  • HOME
  • 검색상세정보

Advancing the discipline of regulatory science for medical product development an update on progress and a forward-looking agenda : workshop summary [electronic resource]

Boname, Morgan L.

책이미지
서평쓰기
서평쓰기
책이미지

QRcode

QR Code
QRcode 사용방법
QRcode 사용방법
QR코드 정의
사각형의 가로세로 격자무늬에 다양한 정보를 담고 있는 2차원(매트릭스)형식의 코드로 스마트폰으로 QR코드를 스캔하면 각종 정보를 제공 받을 수 있습니다.
QR코드 인식프로그램
스마트폰 마켓에 들어가면 'QR코드 스캔 프로그램'을 검색해 무료 어플을 다운받아 사용하시면 됩니다.
도서정보 QR코드 이용하기
도서 상세정보에서 QR코드를 스캔하면, 모바일 웹페이지로 연결되어 해당 도서의 상세정보 및 소장정보 등을 확인 할 수 있습니다.
닫기
상세정보
자료유형E-BOOK
서명/저자사항Advancing the discipline of regulatory science for medical product development [electronic resource]: an update on progress and a forward-looking agenda : workshop summary/ Morgan L. Boname, Amanda Wagner Gee, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine.
개인저자Boname, Morgan L.,author,
Gee, Amanda Wagner,author,
Claiborne, Anne B.,author,
단체저자명National Academies of Sciences, Engineering, and Medicine (U.S.). Forum on Drug Discovery, Development, and Translation,issuing body.
발행사항Washington, DC: National Academies Press, [2016].
형태사항1 online resource (1 PDF file (xvi, 87 pages)): illustrations.
기타형태 저록Print version: Advancing the discipline of regulatory science for medical product development. Washington, DC : the National Academies Press, [2016] 0309438845
ISBN9780309438841
0309438845
9780309438858
0309438853
서지주기Includes bibliographical references.
내용주기Introduction -- Characterizing the Implementation science landscape -- Regulatory science applications: using case studies to focus on approaches to advance the discipline -- Regulatory science infrastructure and workforce -- Challenges and opportunities in regulatory science -- Appendix A: Bibliography -- Appendix B: Workshop agenda -- Appendix C: Participant biographies.
요약The field of endeavors known as "regulatory science" has grown out of the need to link and integrate knowledge within and among basic science research, clinical research, clinical medicine, and other specific scientific disciplines whose focus, aggregation, and ultimate implementation could inform biomedical product development and regulatory decision making. Substantial efforts have been devoted to defining regulatory science and communicating its value and role across the scientific and regulatory ecosystems. Investments are also being made in technology infrastructure, regulatory systems, and workforce development to support and advance this burgeoning discipline. In October 2015, the National Academies of Sciences, Engineering, and Medicine held a public workshop to facilitate dialogue among stakeholders about the current state and scope of regulatory science, opportunities to address barriers to the discipline's success, and avenues for fostering collaboration across sectors. Participants explored key needs for strengthening the discipline of regulatory science, including considering what are the core components of regulatory science infrastructure to foster innovation in medical product development. This report summarizes the presentations and discussions from the workshop.
기금정보주기This activity was supported by AbbVie, Inc.; the American Diabetes Association; American Society of Microbiology; Amgen Inc. (Contract No. GHCCOPS-CSARF-63987); Association of American Medical Colleges; AstraZeneca; Baxter BioScience; Burroughs Wellcome Fund (Contract No. 1015149); Critical Path Institute; Doris Duke Charitable Foundation (Contract No. 2015103); Eli Lilly & Co.; FasterCures; Friends of Cancer Research; GlaxoSmithKline (Contract No. 005319); Johnson & Johnson; Merck & Co., Inc. (Contract No. CMO-141224-000649); National Institutes of Health (NIH) (Contract No. HHSN263201200074I; Task Order HHSN26300023): National Cancer Institute (NIH), National Center for Advancing Translational Sciences (NIH), National Institute of Allergy and Infectious Diseases (NIH), National Institute of Mental Health (NIH), and National Institute of Neurological Disorders and Stroke (NIH); New England Journal of Medicine; Pfizer Inc.; Sanofi; Takeda Pharmaceuticals (Contract No. 53108); and U.S. Food and Drug Administration (Contract No. 1R13FD005496-01). Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
회의명Advancing the Discipline of Regulatory Science for Medical Product Development: an Update on Progress and a Forward-Looking Agenda (Workshop) (2015 : Washington, D.C.)
주제명(단체명)United States. --Food and Drug Administration.
주제명(지명)United States
일반주제명Drug Discovery
Government Regulation
Drug and Narcotic Control
Consumer Product Safety
Equipment and Supplies
Therapies, Investigational
Drug development --Technological innovations --United States.
Research.
Pharmaceutical policy --United States.
MEDICAL / Pharmacology
언어영어
바로가기 URL

소장정보

서비스 이용안내
  • 서가에없는책서가에없는책
  • 도서배달서비스도서배달서비스
  • 인쇄인쇄
메세지가 없습니다
No. 등록번호 청구기호 소장처 도서상태 반납예정일 예약 서비스 매체정보
1 EB54557 URL 참조615 중앙도서관 대출가능
서가에없는책 도서배달서비스 인쇄 이미지
2 EB54558 URL 참조615 c.2 중앙도서관 대출가능
서가에없는책 도서배달서비스 인쇄 이미지
3 EB54559 URL 참조615 c.3 중앙도서관 대출가능
서가에없는책 도서배달서비스 인쇄 이미지
4 EB54560 URL 참조615 c.4 중앙도서관 대출가능
서가에없는책 도서배달서비스 인쇄 이미지

청구기호 Browsing

이 분야 인기자료

  • 표지이미지
    그림이라는 위로 : 불안과 두려움을 지난 화가들이 건네...
    윤성희
    빅피시, 2024
  • 표지이미지
    꾸밈없는 언어 : 미스 반 데어 로에의 말과 건축
    노이마이어, 프리츠
    동녘, 2009
  • 표지이미지
    보는 사람, 화가 : 보이지 않는 본질을 끝끝내 바라보...
    최예선
    앤의서재, 2024
  • 표지이미지
    (세상을 바꾼) 건축 : 권력이 만든 건축, 권력을 만...
    서윤영
    다른, 2016
  • 표지이미지
    공간실험일지 = Space lab file
    호서대학교. 실내디자인학과
    Spacetime: 시공문화사, 2009

서평 (0 건)

*주제와 무관한 내용의 서평은 삭제될 수 있습니다.

서평추가

서평추가
별점
별0점
  • 별5점
  • 별4.5점
  • 별4점
  • 별3.5점
  • 별3점
  • 별2.5점
  • 별2점
  • 별1.5점
  • 별1점
  • 별0.5점
  • 별0점
*서평 입력 시 선택한 별점은 전체 별점에 반영됩니다.
제목입력
본문입력

태그

태그추가

태그추가
태그입력
태그보기